English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Objective\udThe aim of this study is to constitute and validate a symptom questionnaire\udto be used in the diagnosis and follow up of patients with OAB that complies\udwith the specific needs of the Turkish society and that allows the assessment\udof both disease symptoms and their effects on quality of life.\udMaterials and Methods\udA total of 78 OAB patients and 90 control patients were included in this\udstudy between January 2007 and June 2007. All included patients underwent\udurine analysis/culture, blood creatinine levels, 3-day voiding dairy, urinary\udultrasonography and plain abdominal graphy evaluations.\udResults\udAmong 168 patients included 99 (58, 95) were males and 69 (41,1%) were\udfemales. Mean age was 47,3 (±17, 2) years. Cronbach alpha value which is\uda determinant of internal consistency was 0.92 for M-OAB questionnaire.\udThe Spearman correlation co- efficient for total score was found to be 0.98\ud(p=0.001) in the test- retest analysis. The highest sensitivity (97%) and\udspecificity (94%) values for the M-OAB questionnaire to make a diagnosis of\udOAB were obtained with a cut off value of 12.5 for the total score.\udConclusion\udThis study shows the development of a reliable and valid OAB specific\udsymptom and quality of assessment tool that is short and easily applicable in\udthe daily clinical practice. This questionnaire can provide the clinicians with\udpractical comfort and a standardized quantification of the patient symptoms

Constitution and Validation of a New Symptom Assessment Tool for Overactive Bladder: Marmara Overactive Bladder Questionnaire (M-OBQ)